We have located links that may give you full text access.
Lipidic Mesophase-embedded Palladium Nanoparticles: Synthesis and Tunable Catalysts in Suzuki-Miyaura Cross Coupling Reactions.
Langmuir : the ACS Journal of Surfaces and Colloids 2018 December 6
Lipidic cubic phases (LCPs) can reduce Pd2+-salts to palladium nanoparticles (PdNPs) of ~ 5 nm size in their confined water channels under mild conditions. The resulting PdNP-containing LCPs were used as nanoreactor scaffolds to catalyze Suzuki-Miyaura cross coupling reactions in the aqueous channels of the mesophase. To turn on catalysis, PdNP-containing LCPs are activated by swelling the aqueous channels of the lipidic framework, thereby enabling diffusion of the water-soluble substrates to the catalysts. The mesophases play a threefold role: they act as the reducing agent for Pd2+, as a limiting template for their growth, and as a support. The system was characterized and investigated by small-angle X-ray scattering (SAXS), cryo-transmission electron microscopy (cryo-TEM), dynamic light scattering (DLS) and nuclear magnetic resonance (NMR). Bulk LCPs as well as three dispersed palladium/lipid hybrid nanoparticle types were applied in catalysis. The latter - liposomes, hexosomes and cubosomes - can be obtained by design through combination of lipid and additive. The Suzuki-Miyaura cross coupling of 5-iodo-2'-deoxyuridine and phenylboronic acid was used as a model reaction to study these systems. Bulk Pd-LCPs deliver the Suzuki-Miyaura product in 24 h in conversions up to 98 % at room temperature, whereas with palladium/lipid dispersions at 40 °C 68 % of the starting material was transformed to the product after 72 h.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app